The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews
Darren Haywood(Melbourne Health), Nicolas H. Hart(University of Technology Sydney), James R. D. Murray(University of Technology Sydney), Helen Wilding(St Vincent's Hospital Melbourne), Janette L. Vardy(The University of Sydney), Raymond J. Chan(Flinders University), Haryana M. Dhillon(The University of Sydney), Alexandre Chan(University of California, Irvine), Oscar Y. Franco‐Rocha(The University of Texas at Austin), Ashley M. Henneghan(The University of Texas at Austin), Susan L. Rossell(St Vincent's Hospital Melbourne), Maryam B. Lustberg(Yale Cancer Center), Evan Dauer(University of Technology Sydney), Megan Crichton(Queensland University of Technology), Norah Elvidge(Queensland University of Technology), Shradha Vasan(St Vincent's Hospital Melbourne)
Cited by 14
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Use and reporting of experience-based codesign studies in the healthcare setting: a systematic review
|BMJ Quality & Safety|2019|243